News

Ulipristal acetate, a new oral emergency contraceptive designed and developed by HRA Pharma, has received approval from the European Commission and the Food and Drug Administration in May

Chi-Med said that the product is produced in Switzerland under an exclusive supply agreement with an independent supplier and has completed the China importation and certification process with

In the study it was observed that the maximal tolerated dose of Inecalcitol is 4mg per day and the response rate to combination treatment reached 85% based on

The Elixir DESyne BD stent combines a low drug dose (5µg/mm stent length) of internally developed macrocyclic lactone Novolimus, a metabolite of sirolimus and a low polymer load

Taiho Pharma said that Abraxane features improved efficacy and safety as well as easier administration compared to solvent-based paclitaxel. Originally, Abraxane was developed by Abraxis BioScience as a

Oracle claimed that Agile PLM 9.3.1 provides deeper product lifecycle analytics, next generation multi-CAD integrations, complex technical documents management, design variant management and other usability and functional enhancements.

Emisphere said that the two digestive hormones utilised in the study are released naturally in proportion to ingested calories and signal satiety, or fullness, to the brain. SNAC

The 12-week, randomised, double-blind, multicenter Phase III study demonstrated that Lixisenatide was safe and well tolerated in patients with type 2 diabetes. The trial result suggested that Lixisenatide

The drug blocks the recently discovered clacitonin-gene related hormone receptor (CGRP), a vasodilator protein believed to be a key player in migraine. Merck initiated the development of Telcagepant